Showing results (2241-2250 of 3,034) with videos related to

Sort By:
Pageof 304
Molecular Carcinogenesis|June 17, 2025
Spatial Transcriptomic Landscape of Canine Oral Squamous Cell CarcinomaStephanie Goldschmidt, Clifford G Tepper, Jack Goon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 16, 2016
rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosisH E Hulst, T Goldschmidt, M A Nitsche, et al.
The Review of Scientific Instruments|November 4, 2011
Compact x-ray microradiograph for in situ imaging of solidification processes: bringing in situ x-ray micro-imaging from the synchrotron to the laboratoryC Rakete, C Baumbach, A Goldschmidt, et al.
Plos One|January 29, 2015
Global myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysisJens Peter Andersen, Martin Bøgsted, Karen Dybkær, et al.
Biochemical and Biophysical Research Communications|August 18, 1997
17beta-estradiol inhibits apoptosis of endothelial cellsR J Alvarez, S J Gips, N Moldovan, et al.
Journal of Medical Economics|February 7, 2026
Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and accessR Aguiar-Ibáñez, D Goldschmidt, Z Y Zhou, et al.
Appetite|August 25, 2016
Association between objective and subjective binge eating and psychopathology during a psychological treatment trial for bulimic symptomsAndrea B Goldschmidt, Erin C Accurso, Ross D Crosby, et al.
Brain Structure & Function|April 12, 2021
Neuroplastin expression is essential for hearing and hair cell PMCA expressionXiao Lin, Michael G K Brunk, Pingan Yuanxiang, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 16, 1982
[Treatment of rectocolic and gastric adenocarcinomas with 5-fluorouracil associated with high doses of folinic acid. Results of an experimental study]D Machover, L Schwarzenberg, E Goldschmidt, et al.
Haematologica|March 20, 2025
Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trialSalomon Manier, Meletios-Athanasios Dimopoulos, Xavier P Leleu, et al.
Pageof 304